Feetsee at BIO-Europe 2026 in Cologne, Germany

On November 9–10, 2026, Feetsee participated in BIO-Europe 2026 in Cologne, Germany — one of Europe’s leading life sciences partnering events, bringing together biotechnology, MedTech, healthcare innovators, and investors from around the world.

Feetsee was represented by CEO Rytis Zajanckauskas and CTO Ramunas Valancius, who joined the Lithuanian National Pavilion at Booth 7-41, highlighting Lithuania’s growing presence in the global MedTech ecosystem.

Throughout the event, Feetsee showcased its innovative contactless diabetic foot monitoring technology, designed to identify early signs of inflammation and help prevent diabetic foot ulcers. The conference provided valuable opportunities to engage with potential partners, investors, and industry leaders, exploring collaborations in diabetic foot care, remote patient monitoring, and medical device distribution.

As Feetsee CEO and Founder Rytis Zajanckauskas emphasized:

“BIO-Europe 2026 is a great opportunity to showcase Lithuanian MedTech innovation and connect with European and international partners, investors, and healthcare innovators. We look forward to building collaborations that will help bring Feetsee’s innovative diabetic foot monitoring technology to more patients worldwide.”

We extend our gratitude to everyone who connected with our team and contributed to meaningful discussions. BIO-Europe 2026 marked another valuable step in strengthening international partnerships and advancing our mission to transform diabetic foot care worldwide.